Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals All requirements for closing the deal, including shareholders’ approval and ending of the ...

Disposal/Strategic Company DecisionMarinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals 28.02.2025 / 10:20 CET/CESTThe issuer is solely ...

*Dose registered for erosive esophagitis and gastroesophageal reflux disease. iv.: Intravenous; NA: Nonavailable. Alex Mejia, MD, Department of Pharmacology and Experimental Therapeutics, Division ...